GenesisCare bounces back as demand increases

Australian-owned cancer treatment network Genesis Cancer Care (GenesisCare) has reported a strong bounce back in FY22 from the Covid-induced losses of the previous year. The company, which announced operating losses of £5.5m in 2021, booked a 20% leap in revenue to £100.4m on the back of increased activity across all its service lines, in particular the…

You must be a HM Subscriber to view this content.

Subscribe Now »